Vol 2, No 5 (2013)

Date published: 2013-10-25

Table of Contents

open access

President’s voice

Prezes ma głos

Leszek Czupryniak

Diabetologia Kliniczna 2013;2(5):159.
Original articles (submitted)

Diabetic foot risk factors in diabetes type 1 patients

Piotr Nehring, Beata Mrozikiewicz-Rakowska, Agnieszka Sobczyk-Kopcioł, Karnafel Waldemar

Diabetologia Kliniczna 2013;2(5):160-164.
Review

Qualifi cation of patients with diabetes to pancreas transplantation alone

Bernadetta Kałuża, Marek Durlik, Władysław Grzeszczak, Grażyna Rydzewska, Edward Franek

Diabetologia Kliniczna 2013;2(5):172-177.

What is known about diabetogenic effects of statins?

Longina Kłosiewicz-Latoszek, Barbara Cybulska

Diabetologia Kliniczna 2013;2(5):178-184.

Clinical remission of type 1 diabetes

Paweł Niedźwiecki, Dorota Zozulińska-Ziółkiewicz

Diabetologia Kliniczna 2013;2(5):185-190.

Sodium-glucose co-transporter-2 (SGLT2) inhibitors: novel oral antidiabetic drugs

Błażej Przybysławski, Piotr Karbowiak, Jacek Rzeszotarski, Lech Walasek

Diabetologia Kliniczna 2013;2(5):191-197.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl